Bill Ackman - Pershing Square Capital Management
As of Q2 2026, Bill Ackman reported 14 long-equity positions worth $19.47B in aggregate.
Copy-investor backtest
- Latest quarter
- +1.96%
- 1-year
- +15.11%
- 3-year
- +41.35%
- 5-year
- +50.23%
- 3-year vs S&P 500
- -31.89%
- 5-year vs S&P 500
- -23.45%
- 5-year top 5
- +52.69%
Return from mechanically copying the disclosed 13F equity portfolio after each filing and rebalancing at the next. The vs S&P 500 figures subtract SPY over that manager's own rebalance dates, so both sides cover the same days; both are price return, excluding dividends. Method & limitations.
Get email alerts when Bill Ackman files a new 13F — sign in or create a free account.
Updated 2026-06-06 from SEC 13F data.
Live quotes available for 6 of 9 rows. Rows without a quote are marked unavailable.
| 1 | QSR | RESTAURANT BRANDS INTL INC | 21.68% | - | 39,150,551 | $1.63B | $41.60 | No quote |
| 2 | CP | CANADIAN PAC RY LTD | 16.87% | Reduce -29.4% | 9,840,890 | $1.27B | $128.79 | No quote |
| 3 | APD | AIR PRODS & CHEMS INC | 14.37% | - | 7,601,140 | $1.08B | $142.04 | No quote |
| 4 | MDLZ | MONDELEZ INTL INC | 13.90% | - | 22,942,225 | $1.04B | $45.51 | No quote |
| 5 | ZTS | ZOETIS INC | 13.38% | Reduce -49.4% | 21,173,188 | $1B | $47.46 | No quote |
| 6 | VRX | VALEANT PHARMACEUTICALS INTL | 5.79% | - | 21,591,122 | $434.85M | No quote | No quote |
| 7 | HHC | HOWARD HUGHES CORP | 5.43% | - | 3,568,017 | $407.9M | No quote | No quote |
| 8 | PAH | PLATFORM SPECIALTY PRODS COR | 5.05% | - | 42,737,394 | $379.51M | No quote | No quote |
| 9 | NOMD | NOMAD HLDGS LTD | 3.54% | - | 33,333,334 | $266M | $7.98 | No quote |